Detection of serum amyloid A-derived proteins in formalin-fixed paraffin-embedded tissues: Reliability of the method and expansion of its spectrum

American Journal of Clinical Pathology

Volumn 108, Issue 3, 1997, Pages 289-294

  Shtrasburg, Shmuel ^a   Livneh, Avi ^a   Pras, Mordechai ^a   Weinstein, Talia ^b   Gal, Rivka ^b,c  

^a HELLER INSTITUTE OF MEDICAL RESEARCH   (Israel)

^b HASHARON HOSPITAL   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Amyloid A; Amyloid diagnosis; Amyloid 2M; Amyloidosis; Goiter; Immunoblotting; SDS electrophoresis

Indexed keywords

AMYLOID A PROTEIN;

AMYLOIDOSIS; ARTICLE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RELIABILITY; TISSUE FIXATION;

EID: 0030865266     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/108.3.289     Document Type: Article

References (51)

1. Kisilevsky R. Proteoglycans, glycosaminoglycans, amyloid-enhancing factor, and amyloid deposition. J Intern Med. 1992;232:515-516.
2. Husby G. Amyloidosis. Semin Arthritis Rheum. 1992;22:67-82.
3. Puchtler H, Sweat F, Levine M. On the binding of Congo red by amyloid. J Histochem Cytochem. 1962;10:355-364.
4. Cohen AS. Proteins of the systemic amyloidoses. Curr Opin Rheumatol. 1994;6:55-67.
5. Elghetany MT, Saleem A. Methods for staining amyloid in tissues: a review. Stain Technol. 1988;63:201-212.
6. Looi LM. An investigation of the protein components of amyloid using immunoperoxidase and permanganate methods on tissue sections. Pathology. 1986;18:137-140.
7. Gallo GR, Feiner HD, Chuba JV, et al. Characterization of tissue amyloid by immunofluorescence microscopy. Clin Immunol Immunopathol. 1986;39:479-490.
8. Tan SY, Pepys MB. Amyloidosis. Histopathology. 1994;25:403-414.
9. Shtrasburg S, Pras M, Langevitch P, Gal R. Demonstration of AA-protein in formalin-fixed, paraffin-embedded tissues. Am J Pathol. 1982;106:141-144.
10. Robbins SL, Cotran RS, Kumar V. Diseases of immunity. In: Pathologic Basis of Disease. 3rd ed. Philadelphia, Pa: WB Saunders Co; 1984:158-213.
11. Feiner HD. Pathology of dysproteinemia: light chain amyloidosis, non-amyloid immunoglobulin deposition disease, cryoglobulinemia syndromes and macroglobulinemia of Waldenström. Hum Pathol. 1988;19:1255-1272.
12. Powers JM, Sullivan L, Rosenthal CJ. Permanganate oxidation of senile cerebral amyloid and its relationship to AA protein. Acta Neuropathol (Berl). 1982;58:275-278.
13. Löfberg H, Thysell H, Westman K, et al. Demonstration and classification of amyloidosis in needle biopsies of the kidneys, with special reference to amyloidosis of the AA-type. Acta Pathol Microbiol Immunol Scand Section A Pathol. 1987;95:357-363.
14. Friedman E, Farfel Z, Goldfarb D, Gafni J. Renal tubular acidosis after prolonged remission of nephrotic syndrome in amyloidosis associated with astrocytoma. South Med J. 1989;82:765-768.
15. Zwas ST, Shpilberg O, Huszar M, Rozenman J. Isolated ectopic lung uptake of technetium 99m methylene diphosphonate on bone scintigraphy in primary amyloidosis. Eur J Nucl Med. 1990;17:282-285.
16. Benharroch D, Sukenik S, Sacks M. Bronchioloalveolar carcinoma and generalized amyloidosis complicating progressive systemic sclerosis. Hum Pathol. 1992;23:839-841.
17. Westermark P, Nilsson GT. Demonstration of amyloid protein AA in old museum specimens. Arch Pathol Lab Med. 1984;108:217-219.
18. Linke RP, Heilmann KS, Nathrath WBJ, Eulitz M. Identification of amyloid A protein in a sporadic Muckle-Wells syndrome: N-terminal amino acid sequence after isolation from formalin-fixed tissue. Lab Invest. 1983;48:698-704.
19. Linke RP. Monoclonal antibodies against amyloid fibril protein AA: production, specificity and use for immunohistochemical localization and classification of AA-type amyloidosis. J Histochem Cytochem. 1984;32:322-328.
20. Picken MM, Pelton K, Frangione B, Gallo G. Primary amyloidosis A: immunohistochemical and biochemical characterization. Am J Pathol. 1987;129:536-542.
21. Linke RP, Huhn D, Casanova S, Donini U. Methods in laboratory investigation: immunoelectron microscopic identification of human AA-type amyloid: exploration of various monoclonal AA-antibodies, methods of fixation, embedding and of other parameters for the protein-A gold method. Lab Invest. 1989;61:691-097.
22. Gal R, Shtrasburg S, Luria M, et al. Amyloid goiter: report of the clinical histological and biochemical features of five cases. Amyloid: Int J Exp Clin Invest. 1995;2:119-125.
23. Prelli F, Pras M, Frangione B. Degradation and deposition of amyloid AA fibrils are tissue specific. Biochemistry. 1987;26:8251-8256.
24. Prelli F, Pras M, Shtrasburg S, Frangione B. Characterization of high molecular weight amyloid A proteins. Scand J Immunol. 1991;33:783-786.
25. Westermark GT, Sletten K, Westermark P. Massive vascular AA-amyloidosis: a histologically and biochemically, distinctive subtype of reactive systemic amyloidosis. Scand J Immunol. 1989;30:605-613.
26. Westermark GT, Sletten K, Grubb A, Westermark P. AA amyloidosis: tissue component-specific association of various protein AA subspecies and evidence of a fourth SAA gene product. Am J Pathol. 1990;137:377-383.
27. Sletten K, Husby G, Natvig JB. The complete amino acid sequence of an amyloid fibril protein AA of unusual size (64 residues). Biochem Biophys Res Commun. 1976;69:19-25.
28. Ein D, Kimura S, Terry WD, Magnotta J, Glenner GG. Amino acid sequence of an amyloid fibril protein of unknown origin. J Biol Chem. 1972;247:5653-5655.
29. Husby G, Sletten K. Chemical and clinical classification of amyloidosis: 1985. Scand J Immunol. 1986;23:253-265.
30. Moyner K, Sletten K, Husby G, Natvig JB. An unusually large (83 amino acid residues) amyloid fibril protein AA from a patient with Waldenström's macroglobulinaemia and amyloidosis. Scand J Immunol. 1980;11:549-554.
31. Skogen B, Sletten K, Lea T, Natvig JB. Heterogeneity of human amyloid protein AA and its related serum protein, SAA. Scand J Immunol. 1983;17:83-88.
32. Westermark GT, Westermark P, Sletten K. Amyloid fibril protein AA: characterization of uncommon subspecies from a patient with rheumatoid arthritis. Lab Invest. 1987;57:57-64.
33. Coria F, Prelli F, Castano EM, et al. β-protein deposition: a pathogenetic link between Alzheimer's disease and cerebral amyloid angiopathies. Brain Res. 1988;463:187-191.
34. Pras M, Zaretzky J, Frangione B, Franklin EC. AA protein in a case of 'primary' or 'idiopathic' amyloidosis. Am J Med. 1980;68:291-294.
35. Kaplan B, German G, Pras M. Isolation and characterization of amyloid proteins using milligram amounts of amyloid-containing tissue. J Liquid Chromatogr. 1993;16:2249-2268.
36. Pras M, Frangione B, Franklin EC, Gafni J. Idiopathic AL-κIV amyloidosis presenting as giant hepatomegaly. Isr J Med Sci. 1982;18:866-869.
37. Wright JR, Calkins E, Humphrey RL. Potassium permanganate reaction in amyloidosis: a histologic method to assist in differentiating forms of this disease. Lab Invest. 1977;36:274-281.
38. Pras M, Prelli F, Franklin EC, Frangione B. Primary structure of an amyloid prealbumin variant in familial polyneuropathy of Jewish origin. Proc Natl Acad Sci USA. 1983;80:539-542.
39. Gorevic PD, Prelli FC, Wright J, Pras M, Frangione B. Systemic senile amyloidosis: identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy. J Clin Invest. 1989;83:836-843.
40. Gal R, Korzetzs A, Schwartz A, Rath-Wolfson L, Gafter U. Systemic distribution of β2-microglobulin derived amyloidosis in patients who undergo long-term hemodialysis: report of seven cases and review of the literature. Arch Pathol Lab Med. 1994;118:718-721.
41. Cornwell GG III, Westermark GT, Pitkanen P, Westermark P. Seminal vesicle amyloid: the first example of exocrine cell origin of an amyloid fibril precursor. J Pathol. 1992;167:297-303.
42. Prophet EB. Laboratory Methods in Histopathology. Washington DC: American Registry of Pathology; 1992:168.
43. Shtrasburg S, Gal R, Pras M. Crush and smear technique for rapid detection and semiquantitation of amyloid deposition. Biotech Histochem. 1991;66:203-207.
44. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
45. Strachan AF, Brandt WF, Woo P, et al. Human serum amyloid A protein: the assignment of the six major isoforms to three published gene sequences and evidence for two genetic loci. J Biol Chem. 1989;264:18368-18373.
46. Shirahama T, Skinner M, Cohen AS, et al. Histochemical and immunohistochemical characterization of amyloid associated with chronic hemodialysis as β2-microglobulin. Lab Invest. 1985;53:705-709.
47. Lavie G, Zuker-Franklin D, Franklin EC. Degradation of serum amyloid A protein by surface associated enzymes of human blood monocytes. J Exp Med. 1978;148:1020-1031.
48. Husebekk A, Skogen B, Husby G, Marhaug G. Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo. Scand J Immunol. 1985;21:283-287.
49. Tape C, Tan R, Nesheim M, Kisilevsky R. Direct evidence for circulating apoSAA as the precursor of tissue AA amyloid deposits. Scand J Immunol. 1988;28:317-324.
50. Levin M, Franklin EC, Frangione B, Pras M. The amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils. J Clin Invest. 1972: 51:2773-2776.
51. Sletten K, Husby G. The complete amino-acid sequence of non-immunoglobulin amyloid fibril protein AS in juvenile rheumatoid arthritis. Eur J Biochem. 1974;41:117-125.